Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin
Pharmaceutics · 04.03.2024 · 16 (3) · 358
DOI: 10.3390/pharmaceutics16030358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 04.03.2024. Verfasst von Gellért Balázs Karvaly und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Semmelweis University, 1089 Budapest, Hungary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Population pharmacokinetic (pop-PK) models constructed for model-informed precision dosing often have limited utility due to the low number of patients recruited. To augment such models, an approach is presented for generating fully artificial quasi-models which can be employed to make individual estimates of pharmacokinetic parameters. Based on 72 concentrations obtained in 12 patients, one- and two-compartment pop-PK models with or without creatinine clearance as a covariate were generated for piperacillin using the nonparametric adaptive grid algorithm. Thirty quasi-models were subsequently generated for each model type, and nonparametric maximum a posteriori probability Bayesian estimates were established for each patient. A significant difference in performance was found between one- and two-compartment models. Acceptable agreement was found between predicted and observed piperacillin concentrations, and between the estimates of the random-effect pharmacokinetic variables obtained using the so-called support points of the pop-PK models or the quasi-models as priors. The mean squared errors of the predictions made using the quasi-models were similar to, or even considerably lower than those obtained when employing the pop-PK models. Conclusion: fully artificial nonparametric quasi-models can efficiently augment pop-PK models containing few support points, to make individual pharmacokinetic estimates in the clinical setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Semmelweis University, 1089 Budapest, Hungary.
- Laboratory of Applied Pharmacokinetics and Bioinformatics, The Saban Research Institute, University of Southern California, Los Angeles, CA 90027, USA.
- Central Department of Anaesthesiology and Intensive Care, Uzsoki Teaching Hospital, 1145 Budapest, Hungary.
- Central Laboratory, Uzsoki Teaching Hospital, 1145 Budapest, Hungary.
ORCID-Profile: Gellért Balázs Karvaly, István Vincze, Michael Noel Neely, István Zátroch, Csaba Kopitkó
Zitieren
APA
Karvaly, G. B., Vincze, I., Neely, M. N., Zátroch, I., Nagy, Z., Kocsis, I., & Kopitkó, C. (2024). Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin. Pharmaceutics, 16(3), 358. https://doi.org/10.3390/pharmaceutics16030358
Vancouver
Karvaly GB, Vincze I, Neely MN, Zátroch I, Nagy Z, Kocsis I, et al. Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin. Pharmaceutics. 2024;16(3):358. doi:10.3390/pharmaceutics16030358
BibTeX
@article{Karvaly2024,
author = {Karvaly, Gellért Balázs and Vincze, István and Neely, Michael Noel and Zátroch, István and Nagy, Zsuzsanna and Kocsis, Ibolya and Kopitkó, Csaba},
title = {Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {3},
pages = {358},
doi = {10.3390/pharmaceutics16030358}
}
EUVIMED